|
MOP
& Operating Policies
Network
Directory
Email
Alias Lists
Bibliography
Training
Budget
Guidance
Regulatory
Resources
QA/QC
Corner
Network
Evaluation
Human
Subject Protection Resources
Meeting
& Call Minutes
Meeting
& Call Calendars
Newsletter
Network
Reports
Public
Data Sets
Network
Templates
Acronym
List
Other
Links
|
|
HPTN
PrEP Meeting 2007
Washington, DC
Tuesday, January 9, 2007
Fifty-five
colleagues involved in Pre-Exposure Prophylaxis research activities
participated in a one-day meeting on January 9, 2007 to identify key
scientific questions for implementation as prevention research
strategies. Participants represented the scientific, advocacy,
pharmaceutical and funding communities. Other topics discussed included
product formulation, study design, proposed study populations, and
lessons learned from completed and ongoing or planned trials as they may
apply to future trials. Key topics included the need for multiple
studies/populations, sample sizes required, impact on different
transmission mechanisms, adherence, resistance, disinhibition and
community preparedness and involvement. The format of the meeting
included brief presentations, followed by discussion. The meeting agenda
and citable presentations (if permission granted) are attached.
Meeting Summary (PDF)
Presentations
Presentations are available in pdf format
only. Click on the hyperlinked titles to view or download individual
presentations.
Presenters and authors
retain copyright over these presentations and requests for use should be
directed accordingly.
| |
Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in
Women: A Phase 2, Double-blind, Randomized, Placebo-controlled
Trial
|
|
Leigh Peterson |
| |
Update on CDC TDF/Truvada Trials
|
|
Lynn Paxton |
| |
The Iniciativa PrEx Study: Safety, Efficacy, Behavior, and
Biology
|
|
Bob Grant |
| |
Pharmacologic Implications of PrEP Formulations, Including
Resistance
|
|
Jim Rooney |
| |
Pre-Exposure Prophylaxis Research Recommendations from a Variety
of Consultations
|
|
Tom Coates |
| |
PrEP Lessons Leaned: Acceptability, Adherence, Disinhibition
|
|
Kate MacQueen |
| |
Community and Communication Challenges in PrEP Trials:
Reflections on Moving Forward
|
|
Lori Heise |
| |
Identification of Gaps in in PrEP Research
|
|
Ken Mayer |
| |
PrEP Concept is a Point of Convergence in Scientific Agendas of
HPTN, MTN & IMPAACT
|
|
Salim Abdool Karim |
| |
MTN 003
|
|
John Mellors |
| |
Statistical Considerations in Design of Post Exposure
Prophylaxis Studies
|
|
Deborah Donnell |
| |
PREP: Some Issues in Trial Design |
|
Tom Fleming |
|
|
